Literature DB >> 8993721

Are people with HIV in London able to die where they plan?

B Guthrie1, M Nelson, B Gazzard.   

Abstract

Being able to die where you plan is a measure of quality of life near death, in that it implies awareness of diagnosis and prognosis, adequate symptom control and involvement in decision-making in late-stage HIV disease. This study presents trends in place of death for patients attending a large central London HIV centre and examines whether patients dying over a 6-month period in 1994 were able to die where they planned. Early in the epidemic almost all people with HIV died in hospital, but in the late 1980s there was an increase in death at home and in hospices. Of people attending this hospital in 1994, 46% died in hospital, 31% at home, 20% in hospices and 2% abroad. A total of 59% of deaths were where the dying person had planned. Most unplanned deaths were in hospital, two-thirds being due to an unexpected deterioration which precluded planning. The rest were a mixture of people waiting for discharge to die elsewhere, and people who wished to continue active treatment. This pattern of place of death is unlikely to change in the near future. It is therefore essential that hospitals can provide for the needs of patients dying on acute wards.

Entities:  

Mesh:

Year:  1996        PMID: 8993721     DOI: 10.1080/09540129650125425

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  3 in total

Review 1.  End-of-life issues in AIDS: the research perspective.

Authors:  P A Grady; A R Knebel; A Draper
Journal:  J R Soc Med       Date:  2001-09       Impact factor: 5.344

Review 2.  [Where do people die?: On the question of dying in institutions].

Authors:  M Thönnes; N R Jakoby
Journal:  Z Gerontol Geriatr       Date:  2011-10       Impact factor: 1.281

3.  Looking beyond where children die: determinants and effects of planning a child's location of death.

Authors:  Veronica Dussel; Ulrika Kreicbergs; Joanne M Hilden; Jan Watterson; Caron Moore; Brian G Turner; Jane C Weeks; Joanne Wolfe
Journal:  J Pain Symptom Manage       Date:  2008-06-06       Impact factor: 3.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.